Serious Health Problems Are Linked to the Essure Birth Control Implant.

The Essure device, manufactured by Bayer AG, has been widely marketed to women as a safe and simple alternative to permanent birth control surgery. Instead of undergoing a surgical procedure, women who opt for Essure have a nickel-titanium coil inserted into each of their fallopian tubes. This causes an inflammatory reaction, thus preventing fertilization.

The Problem.

Since the Essure device was approved by the FDA in 2002, more than half a million women have chosen to use it. However, it has caused harmful results in a number of these users. The FDA has received more than 5,000 complaints from women who have been subjected to these injuries. Some of the serious medical problems reported include:

Unintended pregnancy

Ectopic pregnancy

Miscarriage

Perforation of the uterus and other organs

Migration of the device inside the body

Severe menstrual cramps and abnormal, heavy bleeding

Vaginal infection

Bloating and fatigue

Allergic reactions

Hair loss

Chronic pain

Unexplained weight gain

Depression

Additional operations to remove the device

Death

Be Careful.

The Essure device was intended to be a permanent implant. When it fails, either by migrating or fracturing inside the body, the only way to fix the problem is through surgery. Often, this may mean a total hysterectomy.

On February 29, 2016, the FDA issued a “black box warning” to inform users of potentially life-threatening effects. They also mandated a “Patient Decision Checklist” that doctors and patients must go over before a woman chooses to use the Essure device.

Know Your Rights. Call For Help.

By keeping these alarming adverse events under wraps, Bayer has failed and misled thousands of women. If you or someone you know has suffered injury or because of Essure or become pregnant while using the device, The Yost Legal Group may be able to help. Our team of experienced legal professionals is here to offer you free, individual consultation. Call us at 1-800-YOST-LAW.